BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Targeting SIGLEC7, SIGLEC9 in solid tumors

By Claire Quang, Staff Writer
July 2, 2021 8:48 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Colorectal cancer; melanoma...

BCIQ Company Profiles

The Rockefeller University

BCIQ Target Profiles

Sialic acid binding Ig like lectin 7 (SIGLEC7)

Sialic acid binding Ig like lectin 9 (SIGLEC9)

BCIQ Company Profiles

The Rockefeller University

BCIQ Target Profiles

Sialic acid binding Ig like lectin 7 (SIGLEC7)

Sialic acid binding Ig like lectin 9 (SIGLEC9)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS